Claudin‐12‐Expressing Fibroblasts Facilitate Metastatic Spread of Pancreatic Cancer Through Physical Interactions
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71114 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 31.10.2026. Verfasst von Qingcui Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Henan China-Germany International Joint Laboratory of Tumor Immune Microenvironment and Disease the First Affiliated Hospita…. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Claudins (CLDNs), as major components of tight junctions in epithelial cells, are emerging as attractive non‐mutant targets for controlling the growth and metastasis of various cancers. However, the mechanisms by which CLDNs modulate tumor progression remain largely unclear. Here, we unexpectedly found that CLDN12 is expressed in cancer‐associated fibroblasts (CAFs), which are generally not considered tight junction‐forming cells. CLDN12 expression in fibroblasts increased their motility and, importantly, promoted direct adhesion to pancreatic cancer cells through homophilic CLDN12–CLDN12 interactions. This CLDN12‐dependent physical interaction between fibroblasts and tumor cells markedly enhanced cancer cell invasion. Moreover, TGF‐β produced by cancer cells further induced the upregulation of CLDN12 expression in fibroblasts. In vivo, CLDN12‐positive fibroblasts facilitated distant metastasis of pancreatic cancer to liver and diaphragm. Targeting CLDN12 with the synthetic peptide C12‐pm efficiently decreased the liver metastasis of pancreatic cancer. Taken together, these findings reveal a previously unrecognized role of CLDN12‐expressing fibroblasts in promoting pancreatic cancer metastasis through direct physical interactions with tumor cells and highlight CLDN12‐mediated interactions as a potential therapeutic target for metastatic pancreatic cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Research Center, Henan China-Germany International Joint Laboratory of Tumor Immune Microenvironment and Disease the First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China.
- Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study University of Chinese Academy of Sciences Hangzhou Zhejiang China.
- Department of Gastroenterology Infectious Diseases and Rheumatology Charité-Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Q., Miao, X., Yang, Y., Chen, R., Fang, Q., Duan, X., Lou, X., Yao, X., Zhang, L., Glauben, R., Qin, Z., & Ni, C. (2026). Claudin‐12‐Expressing Fibroblasts Facilitate Metastatic Spread of Pancreatic Cancer Through Physical Interactions. MedComm, 7(11). https://doi.org/10.1002/mco2.71114
Vancouver
Li Q, Miao X, Yang Y, Chen R, Fang Q, Duan X, et al. Claudin‐12‐Expressing Fibroblasts Facilitate Metastatic Spread of Pancreatic Cancer Through Physical Interactions. MedComm. 2026;7(11). doi:10.1002/mco2.71114
BibTeX
@article{Li2026,
author = {Li, Qingcui and Miao, Xiangjing and Yang, Yuanyuan and Chen, Ruoyang and Fang, Qingqing and Duan, Xixi and Lou, Xiaohan and Yao, Xiaohan and Zhang, Lijing and Glauben, Rainer and Qin, Zhihai and Ni, Chen},
title = {Claudin‐12‐Expressing Fibroblasts Facilitate Metastatic Spread of Pancreatic Cancer Through Physical Interactions},
journal = {MedComm},
year = {2026},
volume = {7},
number = {11},
doi = {10.1002/mco2.71114}
}
EUVIMED